Opus Genetics, Inc. (IRD)
5.11
-0.15
(-2.85%)
USD |
NASDAQ |
May 07, 11:41
Opus Genetics Free Cash Flow : -35.25M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Keros Therapeutics, Inc. | 105.95M |
| Moderna, Inc. | -1.603B |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Savara, Inc. | -101.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.833M |
| Cash from Financing (Quarterly) | 24.11M |
| Free Cash Flow Per Share (Quarterly) | -0.1407 |
| Free Cash Flow to Equity (Quarterly) | -9.894M |
| Free Cash Flow to Firm (Quarterly) | -9.772M |
| Free Cash Flow Yield | -11.60% |